Literature DB >> 28294537

Beyond histones - the expanding roles of protein lysine methylation.

Zhouran Wu1, Justin Connolly2, Kyle K Biggar2.   

Abstract

A robust signaling network is essential for cell survival. At the molecular level, this is often mediated by as many as 200 different types of post-translational modifications (PTMs) that are made to proteins. These include well-documented examples such as phosphorylation, ubiquitination, acetylation and methylation. Of these modifications, non-histone protein lysine methylation has only recently emerged as a prevalent modification occurring on numerous proteins, thus extending its role well beyond the histone code. To date, this modification has been found to regulate protein activity, protein-protein interactions and interplay with other PTMs. As a result, lysine methylation is now known to be a coordinator of protein function and is a key driver in several cellular signaling events. Recent advances in mass spectrometry have also allowed the characterization of a growing number of lysine methylation events on an increasing number of proteins. As a result, we are now beginning to recognize lysine methylation as a dynamic event that is involved in a number of biological processes, including DNA damage repair, cell growth, metabolism and signal transduction among others. In light of current research advances, the stage is now set to study the extent of lysine methylation that exists within the entire proteome, its dynamics, and its association with physiological and pathological processes.
© 2017 Federation of European Biochemical Societies.

Entities:  

Keywords:  non-histone lysine methylation; post-translational modification; protein modification

Mesh:

Substances:

Year:  2017        PMID: 28294537     DOI: 10.1111/febs.14056

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  27 in total

1.  Discovery of Isoxazole Amides as Potent and Selective SMYD3 Inhibitors.

Authors:  Dai-Shi Su; Junya Qu; Mark Schulz; Chuck W Blackledge; Hongyi Yu; Jenny Zeng; Joelle Burgess; Alexander Reif; Melissa Stern; Raman Nagarajan; Melissa Baker Pappalardi; Kristen Wong; Alan P Graves; William Bonnette; Liping Wang; Patricia Elkins; Beth Knapp-Reed; Jeffrey D Carson; Charles McHugh; Helai Mohammad; Ryan Kruger; Juan Luengo; Dirk A Heerding; Caretha L Creasy
Journal:  ACS Med Chem Lett       Date:  2019-12-27       Impact factor: 4.345

2.  Integration of protein phosphorylation, acetylation, and methylation data sets to outline lung cancer signaling networks.

Authors:  Mark Grimes; Benjamin Hall; Lauren Foltz; Tyler Levy; Klarisa Rikova; Jeremiah Gaiser; William Cook; Ekaterina Smirnova; Travis Wheeler; Neil R Clark; Alexander Lachmann; Bin Zhang; Peter Hornbeck; Avi Ma'ayan; Michael Comb
Journal:  Sci Signal       Date:  2018-05-22       Impact factor: 8.192

Review 3.  Proteins and Proteoforms: New Separation Challenges.

Authors:  Fred E Regnier; JinHee Kim
Journal:  Anal Chem       Date:  2017-12-18       Impact factor: 6.986

4.  Targeting SMYD2 inhibits angiogenesis and increases the efficiency of apatinib by suppressing EGFL7 in colorectal cancer.

Authors:  Yi Zhang; Lei Zhou; Yixin Xu; Jingyu Zhou; Tao Jiang; Jiaqi Wang; Chao Li; Xiaoxiong Sun; Hu Song; Jun Song
Journal:  Angiogenesis       Date:  2022-05-03       Impact factor: 9.596

5.  Future Prospects for Epigenetics in Autism Spectrum Disorder.

Authors:  Logan A Williams; Janine M LaSalle
Journal:  Mol Diagn Ther       Date:  2022-08-13       Impact factor: 4.476

Review 6.  Epigenetic signatures in cardiac fibrosis, special emphasis on DNA methylation and histone modification.

Authors:  Hui Tao; Zheng-Yu Song; Xuan-Sheng Ding; Jing-Jing Yang; Kai-Hu Shi; Jun Li
Journal:  Heart Fail Rev       Date:  2018-09       Impact factor: 4.214

7.  The ribosome: A hot spot for the identification of new types of protein methyltransferases.

Authors:  Steven G Clarke
Journal:  J Biol Chem       Date:  2018-05-09       Impact factor: 5.157

Review 8.  The clever strategies used by intracellular parasites to hijack host gene expression.

Authors:  Marie Villares; Jérémy Berthelet; Jonathan B Weitzman
Journal:  Semin Immunopathol       Date:  2020-01-30       Impact factor: 9.623

9.  Smyd1 is essential for myosin expression and sarcomere organization in craniofacial, extraocular, and cardiac muscles.

Authors:  Shuang Jiao; Rui Xu; Shaojun Du
Journal:  J Genet Genomics       Date:  2021-04-07       Impact factor: 5.723

10.  SETD7-mediated monomethylation is enriched on soluble Tau in Alzheimer's disease.

Authors:  Maria Bichmann; Nuria Prat Oriol; Ebru Ercan-Herbst; David C Schöndorf; Borja Gomez Ramos; Vera Schwärzler; Marie Neu; Annabelle Schlüter; Xue Wang; Liang Jin; Chenqi Hu; Yu Tian; Janina S Ried; Per Haberkant; Laura Gasparini; Dagmar E Ehrnhoefer
Journal:  Mol Neurodegener       Date:  2021-07-02       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.